Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs72813571 | chr2:61599786 | T/C | 6.44E-5 | 177 | 24.1 | 30.93 | 10.3 | KM Plot |
PCPG | rs72813572 | chr2:61599888 | G/A | 6.81E-5 | 177 | 23.43 | 30.33 | 10.3 | KM Plot |
PCPG | rs72836090 | chr17:50309650 | A/G | 5.96E-5 | 178 | 25.4 | 29.7 | 14.47 | KM Plot |
PCPG | rs7286982 | chr22:25619025 | A/C | 0.000175 | 178 | 25.17 | 27.27 | 18.82 | KM Plot |
PCPG | rs7287892 | chr22:21291329 | C/A | 7.74E-5 | 177 | 12.57 | 31.68 | 25.2 | KM Plot |
PCPG | rs72887782 | chr17:74933161 | A/G | 1.98E-5 | 170 | 24.77 | 25.87 | 25.17 | KM Plot |
PCPG | rs7290490 | chr22:21291263 | T/C | 7.74E-5 | 177 | 12.93 | 31.47 | 25.2 | KM Plot |
PCPG | rs72952700 | chr2:217030000 | G/A | 6.65E-5 | 177 | 24.85 | 28.87 | 2.93 | KM Plot |
PCPG | rs72954633 | chr2:217049597 | T/C | 7.45E-5 | 175 | 25 | 29.43 | 2.93 | KM Plot |
PCPG | rs72959038 | chr2:228480549 | G/A | 6.79E-11 | 175 | 24.53 | 36.73 | 10.3 | KM Plot |
PCPG | rs72975283 | chr11:103966694 | C/T | 6.89E-11 | 175 | 25.87 | 16.87 | 10.3 | KM Plot |
PCPG | rs73054651 | chr3:182610029 | A/G | 1.06E-5 | 174 | 25.87 | 27.2 | 11.78 | KM Plot |
PCPG | rs73054652 | chr3:182610584 | G/A | 1.06E-5 | 174 | 25.87 | 27.2 | 11.78 | KM Plot |
PCPG | rs73054663 | chr3:182633062 | C/T | 0.000133 | 175 | 25.87 | 27.2 | 13.27 | KM Plot |
PCPG | rs73066801 | chr12:13084119 | C/T | 0.000183 | 171 | 25.17 | 25.43 | 21.03 | KM Plot |